Last reviewed · How we verify

NCT05560048

Anti-exercise-fatigue Effects of Rice Protein RP-80NY in Men

Status unknown NA Last updated 30 November 2022
What this trial tests

NA trial testing rice protein RP-80N in Healthy in 18 participants. Status unknown.

Timeline
30 September 2022
Primary endpoint
15 December 2022
30 January 2023

Quick facts

Lead sponsorChung Shan Medical University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposeprevention
Enrollment18
Start date30 September 2022
Primary completion15 December 2022
Estimated completion30 January 2023
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Chung Shan Medical University

Who can join

Adults 20 to 40, male only, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the anti-exercise-fatigue effects of rice protein RP-80NY in men

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Chung Shan Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05560048.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing